Melanoderma, diffuseL81.4

Author:Prof. Dr. med. Peter Altmeyer

Last updated on: 29.10.2020

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Large or universal hyperpigmentation of the integument due to diffuse melanocyte proliferation in the epidermis and/or dermis.

EtiopathogenesisThis section has been translated automatically.

Melanoderma is observed in the following diseases:

Endocrine diseases:

M. Addison
ACTH- and/or MSH-forming tumors of the pituitary gland
Acromegaly
Hyperthyroidism.

Internal diseases:

Cirrhosis of the liver
malignant lymphogranulomatosis
Hemochromatosis
Encephalitis.
chronic infectious diseases.

In/after dermatoses of different genesis:

systemic scleroderma
Dermatomyositis
after erythroderma (melanoerythroderma)
rarely in metastatic malignant melanoma.

Through medication:

Arsenic; silver or gold containing medicines (argyrosis, chrysiasis)
Chlorpromazine
Chloroquine.

TherapyThis section has been translated automatically.

S. under the respective dermatosis.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer